Medical Oncology Grand Rounds

2021-2022 Academic Year

Date Speaker Title
Sep 24, 2021 Whitney Hensing Targeting HER2 in Breast Cancer: New Drugs and Paradigms
Oct 8, 2021 Rigoberto Pizarro Overview of Health Disparities in Cancer
Fahrettin Covut Minimal Residual Disease in Multiple Myeloma
Oct 15, 2021 Raya Saba Updates in Frontline Treatment of Chronic Lymphocytic Leukemia
Andrew Young Liquid Biopsy for Cancer Screening
Oct 22, 2021 Eric Schwartz Financial Burdens Surrounding Oral Cancer Therapy
Oct 29, 2021 Patricia Ribeiro Pereira Non-Invasive Nuclear Imaging of Cancer Biology to Convert Non-Responders Into Responders
Nov 5, 2021 Melissa Reimers Updates and Recent Advances in Renal Cell Carcinoma
Nov 12, 2021 Daniel Link Clonal Hematopoiesis: Etiology and Evolution
Nov 19, 2021 Armin Ghobadi Cellular Therapies for Cancer - A Primer and an Update
Nov 26, 2021 Canceled - Holiday
Dec 3, 2021 Canceled - ASH Meeting
Dec 10, 2021 Canceled - ASH Meeting
Dec 17, 2021 Canceled
Dec 24, 2021 Canceled - Holiday
Dec 31, 2021 Canceled - Holiday
Jan 7, 2022 Patrick White Innovative Tools and Strategies for Enhancing Support for Your Oncology Patients and Caregivers
Jan 14, 2022 Canceled
Jan 21, 2022 Matthew Walter Clonal Evolution of Myelodysplastic Syndromes
Jan 28, 2022 Srivatsan Raghavan The Tumor Microenvironment Drives Cell State, Plasticity, and Drug Response in Pancreatic Cancer
Feb 4, 2022 Sheila Stewart Age-Related Stromal Changes Drive Tumor Progression
Feb 11, 2022 Giordano Cittolin-Santos Neoadjuvant Immunotherapy in NSCLC
Jared Cohen The Changing Landscape of Treatment in DLBCL
Feb 18, 2022 Ravi Vij Multiple Myeloma: The Best Is Yet to Come!
Feb 25, 2022 Joshua Rubin Adapting Cancer Treatment to Sex Differences in Cancer Biology
Mar 4, 2022 Jason Weber Identification of Drivers and Vulnerabilities in Breast Cancer
Mar 11, 2022 Jing Wu Translational Research in Developing a CDK9 Inhibitor Towards a Glioma Treatment
Mar 18, 2022 Canceled
Mar 25, 2022 Bindiya Patel Biomarkers to Guide Adjuvant Therapy in Early-Stage NSCLC
Michael Kramer The Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia
Apr 1, 2022 Joseph Franses
Massachusetts General Hospital
Identifying and Targeting Metastatic and Microenvironmental Drivers in Hepatocellular Carcinoma
Apr 8, 2022 Todd Fehniger Activate and Recollect: Training Natural Killer Cells for Cancer Immunotherapy
Apr 15, 2022 Jing Xi A Silent Epidemic? – Disparities in Breast Cancer for Sexual and Gender Minority Women
Apr 22, 2022 Miriam Jacobs Applications of Memory-Like Natural Killer Cells for Head and Neck Cancer Immunotherapy
Apr 29, 2022 Michael Gillette
Broad Institute, Cambridge, MA
Deep Integrated Proteogenomics Reveals New Biology and Therapeutic Vulnerabilities in Non-Small Cell Lung Cancer
May 6, 2022 Foluso Ademuyiwa and Mark Fiala Racial Disparities in Oncology: Challenges and Opportunities
May 13, 2022 Michael Iglesia Metastasis in Colorectal Cancer
May 20, 2022 Milan Chheda Tuning In: A Review of Psychedelics for Patients With Cancer
May 27, 2022 Nicole Foley T-Cell Lymphomas and HSCT
Michael Slade Why CARs Crash: CAR T Cell Treatment Failure and the PD-1/PD-L1 Axis
Jun 3, 2022 Canceled - ASCO Meeting
Jun 10, 2022 Timothy Ley AML Proteomics and Interactomics
Jun 17, 2022 Omar Butt The Intersection of the Blood Brain Barrier, Neuro-Inflammation, and Neuro-Degeneration in Neuro-Oncology
Jun 24, 2022 Charles Swanton
Francis Crick Institute, London, UK
Paul Calabresi K12 Visiting Professor
Lung Cancer Evolution, Metastases and Immune Evasion: Insights From TRACERx